About
.....
About Celliaz
Pioneering Retinal
Regeneration
Restoring Vision Through Regenerative Science
Celliaz is a biotechnology company developing next-generation
regenerative therapeutics for retinal degenerative diseases.
Founded on breakthrough discoveries from KAIST research,
Celliaz is pioneering innovative approaches to restore vision
by unlocking the regenerative potential of damaged retinal
tissue and ultimately restoring lost vision.
Core Competencies
Vision Restoration
Moving beyond symptom control
to restore vision through
retinal regeneration.
CLZ001 Innovation
Developing first-in-class
therapies that remove biological
arriers to retinal repair.
Universal Applicability
Targeting regenerative
mechanisms rather than
individual mutations
Global Opportunity
Creating scalable regenerative therapies for patients worldwide.
Our Vision for the Future
A new Paradigm for
Vision Recovery
Celliaz is advancing a new generation of regenerative therapeutics
designed to restore vision rather than merely delay its loss.
Building on proprietary discoveries in retinal regeneration,
we continue to expand our platform technologies,
strengthen global partnerships, and accelerate the path toward clinical
development and commercialization.